Literature DB >> 10598581

Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.

D L Russell1, J S Richards.   

Abstract

PRL activates an important cytokine signaling cascade that is obligatory for maintaining luteal cell function in the rat ovary. To determine when specific components of this cascade are expressed and can be activated by PRL, we analyzed the expression of receptor subtypes (short, PRL-R(s), and long, PRL-R(L)), the presence and kinetics of Stat (signal transducer and activator of transcription) activation using the PRL-response element (PRL-RE) of the alpha2M (alpha2-macroglobulin) gene, and the content and hormonal regulation of three specific modulators of cytokine signaling; the tyrosine phosphatases (SHP-1 and SHP-2), and the protein inhibitor of activated Stat3 (PIAS-3). These components were analyzed in differentiating granulosa/ luteal cells of hypophysectomized (H) rats and in corpora lutea of pregnant rats. Levels of PRL-R mRNAs increased as granulosa cells differentiated and reached maximal levels in luteal cells of pregnant rats where levels of PRL-R(s) approached those of PRL-R(L). The relative concentrations shifted from a 27-fold excess of PRL-R(L) in preovulatory granulosa cells to a 3.7-fold difference in luteal cells during midgestation. Despite the increased PRL-R(L) expression in differentiated granulosa cells, PRL did not stimulate detectable activation of Stats. Rather PRL activation of Stat5, principally Stat5b, occurred in association with luteinization. In contrast, granulosa cells of untreated immature and H rats contained a high level of DNA binding activity, which was shown to be comprised entirely of activated, phosphorylated Stat3. Treatment with estrogen and FSH reduced the amount of phosphorylated Stat3 and abolished its ability to bind DNA, an effect temporally related to increased PIAS-3. Expression of SHP-1 (but not SHP-2) was also hormonally regulated; SHP-1 mRNA and protein were high in granulosa cells of H rats, decreased by estrogen and FSH, and subsequently increased dramatically with luteinization. Of particular note, SHP-1 was localized in cytoplasm of granulosa cells in atretic follicles but was distinctly nuclear in luteal cells, indicative of different functional roles. Collectively, these results indicate that Stat3 and Stat5 are activated by distinct cytokine-signaling pathways modulated through differentiation-dependent transcriptional regulation of signaling pathway components and mediate distinct functional processes in the rat ovary: early follicle growth and atresia vs. luteinization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598581     DOI: 10.1210/mend.13.12.0389

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

1.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

Review 2.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

3.  A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.

Authors:  Midori Kitayama; Kiyohito Mizutani; Masahiro Maruoka; Kenji Mandai; Shotaro Sakakibara; Yuki Ueda; Takahide Komori; Yohei Shimono; Yoshimi Takai
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

Review 4.  Unique bioactivities of bone morphogenetic proteins in regulation of reproductive endocrine functions.

Authors:  Fumio Otsuka; Kenichi Inagaki
Journal:  Reprod Med Biol       Date:  2011-04-14

5.  Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.

Authors:  Y Sangeeta Devi; Anita M Seibold; Aurora Shehu; Evelyn Maizels; Julia Halperin; Jamie Le; Nadine Binart; Lei Bao; Geula Gibori
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

6.  Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.

Authors:  Jamie A Le; Heather M Wilson; Aurora Shehu; Jifang Mao; Y Sangeeta Devi; Julia Halperin; Tetley Aguilar; Anita Seibold; Evelyn Maizels; Geula Gibori
Journal:  Biol Reprod       Date:  2012-03-22       Impact factor: 4.285

7.  Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase.

Authors:  S Rocchi; I Gaillard; E van Obberghen; E M Chambaz; I Vilgrain
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

8.  Microarray analysis of Foxl2 mediated gene regulation in the mouse ovary derived KK1 granulosa cell line: Over-expression of Foxl2 leads to activation of the gonadotropin releasing hormone receptor gene promoter.

Authors:  Jean M Escudero; Jodi L Haller; Colin M Clay; Kenneth W Escudero
Journal:  J Ovarian Res       Date:  2010-02-18       Impact factor: 4.234

9.  IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.

Authors:  Ping Zhou; Sarah C Baumgarten; Yanguang Wu; Jill Bennett; Nicola Winston; Jennifer Hirshfeld-Cytron; Carlos Stocco
Journal:  Mol Endocrinol       Date:  2013-01-22

10.  Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.

Authors:  Julia Halperin; Y Sangeeta Devi; Sangeeta Y Devi; Shai Elizur; Carlos Stocco; Aurora Shehu; Diane Rebourcet; Terry G Unterman; Nancy D Leslie; Jamie Le; Nadine Binart; Geula Gibori
Journal:  Mol Endocrinol       Date:  2007-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.